161 related articles for article (PubMed ID: 31586452)
1. Evaluation of the Betulinic Acid-Cisplatin conjugate APC and its precursor DE9B for the treatment of human malignant glioma.
Bache M; Hein A; Petrenko M; Güttler A; Keßler J; Wichmann H; Kappler M; Emmerich D; Paschke R; Vordermark D
Chem Biol Interact; 2019 Dec; 314():108841. PubMed ID: 31586452
[TBL] [Abstract][Full Text] [Related]
2. Increased betulinic acid induced cytotoxicity and radiosensitivity in glioma cells under hypoxic conditions.
Bache M; Zschornak MP; Passin S; Kessler J; Wichmann H; Kappler M; Paschke R; Kaluđerović GN; Kommera H; Taubert H; Vordermark D
Radiat Oncol; 2011 Sep; 6():111. PubMed ID: 21906280
[TBL] [Abstract][Full Text] [Related]
3. alpha-Mangostin enhances betulinic acid cytotoxicity and inhibits cisplatin cytotoxicity on HCT 116 colorectal carcinoma cells.
Aisha AF; Abu-Salah KM; Ismail Z; Majid AM
Molecules; 2012 Mar; 17(3):2939-54. PubMed ID: 22402764
[TBL] [Abstract][Full Text] [Related]
4. Betulinic acid derivatives NVX-207 and B10 for treatment of glioblastoma--an in vitro study of cytotoxicity and radiosensitization.
Bache M; Bernhardt S; Passin S; Wichmann H; Hein A; Zschornak M; Kappler M; Taubert H; Paschke R; Vordermark D
Int J Mol Sci; 2014 Oct; 15(11):19777-90. PubMed ID: 25361208
[TBL] [Abstract][Full Text] [Related]
5. Betulinic acid induces apoptosis and inhibits metastasis of human colorectal cancer cells in vitro and in vivo.
Zeng A; Hua H; Liu L; Zhao J
Bioorg Med Chem; 2019 Jun; 27(12):2546-2552. PubMed ID: 30910472
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and studies of anticancer properties of lupane-type triterpenoid derivatives containing a cisplatin fragment.
Emmerich D; Vanchanagiri K; Baratto LC; Schmidt H; Paschke R
Eur J Med Chem; 2014 Mar; 75():460-6. PubMed ID: 24561674
[TBL] [Abstract][Full Text] [Related]
7. Betulinic acid induces apoptosis and inhibits metastasis of human renal carcinoma cells in vitro and in vivo.
Yang C; Li Y; Fu L; Jiang T; Meng F
J Cell Biochem; 2018 Nov; 119(10):8611-8622. PubMed ID: 29923216
[TBL] [Abstract][Full Text] [Related]
8. Combination of amino acid/dipeptide with ligustrazine-betulinic acid as antitumor agents.
Xu B; Yan WQ; Xu X; Wu GR; Zhang CZ; Han YT; Chu FH; Zhao R; Wang PL; Lei HM
Eur J Med Chem; 2017 Apr; 130():26-38. PubMed ID: 28237794
[TBL] [Abstract][Full Text] [Related]
9. Self-assembled betulinic acid protects doxorubicin induced apoptosis followed by reduction of ROS-TNF-α-caspase-3 activity.
Dash SK; Chattopadhyay S; Ghosh T; Dash SS; Tripathy S; Das B; Bag BG; Das D; Roy S
Biomed Pharmacother; 2015 May; 72():144-57. PubMed ID: 26054689
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of Rhodamine-Conjugated Lupane Type Triterpenes of Enhanced Cytotoxicity.
Denner TC; Heise NV; Hoenke S; Csuk R
Molecules; 2024 May; 29(10):. PubMed ID: 38792206
[TBL] [Abstract][Full Text] [Related]
11. A 3D QSAR study of betulinic acid derivatives as anti-tumor agents using topomer CoMFA: model building studies and experimental verification.
Ding W; Sun M; Luo S; Xu T; Cao Y; Yan X; Wang Y
Molecules; 2013 Aug; 18(9):10228-41. PubMed ID: 23973995
[TBL] [Abstract][Full Text] [Related]
12. Betulinic acid-induced apoptosis in glioma cells: A sequential requirement for new protein synthesis, formation of reactive oxygen species, and caspase processing.
Wick W; Grimmel C; Wagenknecht B; Dichgans J; Weller M
J Pharmacol Exp Ther; 1999 Jun; 289(3):1306-12. PubMed ID: 10336521
[TBL] [Abstract][Full Text] [Related]
13. Betulinic acid self-assembled nanoparticles for effective treatment of glioblastoma.
Li Y; Wang Y; Gao L; Tan Y; Cai J; Ye Z; Chen AT; Xu Y; Zhao L; Tong S; Sun Q; Liu B; Zhang S; Tian D; Deng G; Zhou J; Chen Q
J Nanobiotechnology; 2022 Jan; 20(1):39. PubMed ID: 35062946
[TBL] [Abstract][Full Text] [Related]
14. Betulinic acid decreases expression of bcl-2 and cyclin D1, inhibits proliferation, migration and induces apoptosis in cancer cells.
Rzeski W; Stepulak A; Szymański M; Sifringer M; Kaczor J; Wejksza K; Zdzisińska B; Kandefer-Szerszeń M
Naunyn Schmiedebergs Arch Pharmacol; 2006 Oct; 374(1):11-20. PubMed ID: 16964520
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization and augmented anticancer potential of PEG-betulinic acid conjugate.
Saneja A; Sharma L; Dubey RD; Mintoo MJ; Singh A; Kumar A; Sangwan PL; Tasaduq SA; Singh G; Mondhe DM; Gupta PN
Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():616-626. PubMed ID: 28183653
[TBL] [Abstract][Full Text] [Related]
16. Betulinic Acid Restricts Human Bladder Cancer Cell Proliferation In Vitro by Inducing Caspase-Dependent Cell Death and Cell Cycle Arrest, and Decreasing Metastatic Potential.
Kim SY; Hwangbo H; Kim MY; Ji SY; Kim DH; Lee H; Kim GY; Moon SK; Leem SH; Yun SJ; Kim WJ; Cheong J; Park C; Choi YH
Molecules; 2021 Mar; 26(5):. PubMed ID: 33806566
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of heterocycle-modified betulinic acid derivatives as antitumor agents.
Cui HW; He Y; Wang J; Gao W; Liu T; Qin M; Wang X; Gao C; Wang Y; Liu MY; Yi Z; Qiu WW
Eur J Med Chem; 2015 May; 95():240-8. PubMed ID: 25817774
[TBL] [Abstract][Full Text] [Related]
18. Betulinic acid promotes TRAIL function on liver cancer progression inhibition through p53/Caspase-3 signaling activation.
Xu Y; Li J; Li QJ; Feng YL; Pan F
Biomed Pharmacother; 2017 Apr; 88():349-358. PubMed ID: 28119237
[TBL] [Abstract][Full Text] [Related]
19. Betulinic acid enhanced the chemical sensitivity of esophageal cancer cells to cisplatin by inducing cell pyroptosis and reducing cell stemness.
Chen J; Peng R; Niu Z; Zhou H; Kang C
Ann Palliat Med; 2020 Jul; 9(4):1912-1920. PubMed ID: 32575994
[TBL] [Abstract][Full Text] [Related]
20. Betulinic acid and its derivatives: a patent review (2008-2013).
Csuk R
Expert Opin Ther Pat; 2014 Aug; 24(8):913-23. PubMed ID: 24909232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
